Immune Thrombocytopenia in Patients with Connective Tissue Disorders and the Antiphospholipid Antibody Syndrome

Hematology/Oncology Clinics of North America

Volumn 23, Issue 6, 2009, Pages 1239-1249

  Arkfeld, Daniel G ^a   Weitz, Ilene C ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Antiphospholipid antibody syndrome; Lupus; Rheumatoid arthritis; Sj gren syndrome; Still disease; Thrombocytopenia

Indexed keywords

ACETYLSALICYLIC ACID; ADALIMUMAB; ANTICOAGULANT AGENT; ANTIMALARIAL AGENT; ANTIRHEUMATIC AGENT; AZATHIOPRINE; CERTOLIZUMAB PEGOL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; GOLIMUMAB; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RITUXIMAB; SALAZOSULFAPYRIDINE; TOCILIZUMAB; TUMOR NECROSIS FACTOR INHIBITOR;

ADULT ONSET STILL DISEASE; ANCA ASSOCIATED VASCULITIS; ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNE THROMBOCYTOPENIA; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CONNECTIVE TISSUE DISEASE; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG RESPONSE; HUMAN; IMMUNOREGULATION; INCIDENCE; JUVENILE RHEUMATOID ARTHRITIS; MIXED CONNECTIVE TISSUE DISEASE; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; RISK REDUCTION; SJOEGREN SYNDROME; SKIN BLEEDING; SPLENECTOMY; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOSIS; VASCULITIS;

ANTIPHOSPHOLIPID SYNDROME; BLOOD PLATELETS; CONNECTIVE TISSUE DISEASES; HUMANS; PLATELET COUNT; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC;

EID: 70449636017     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2009.08.010     Document Type: Review

References (75)

1. Arkfeld D.G. The potential utility of B cell-directed biologic therapy in autoimmune diseases. Rheumatol Int 28 (2008) 205-215
2. McMillan R. Therapy for adults with refractory chronic immune thrombocytopenic purpura. Ann Intern Med 126 (1997) 307-314
3. Altintas A., Ozel A., Okur N., et al. Prevalence and clinical significance of elevated antinuclear antibody test in children and adult patients with idiopathic thrombocytopenic purpura. J Thromb Thrombolysis 24 (2007) 163-168
4. Karpatkin S., and Lackner H.L. Association of antiplatelet antibody with functional platelet disorders. Autoimmune thrombocytopenic purpura, systemic lupus erythematosus and thrombopathia. Am J Med 59 (1975) 599-604
5. Cines D.B., Bussel J.B., Liebman H.A., et al. The ITP syndrome: a diverse set of disorders with different immune mechanisms. Blood 113 (2009) 6511-6521
6. Asahi A., Nishimoto T., Okazaki Y., et al. Helicobacter pylori eradication shifts monocyte Fcγ receptor balance toward inhibitory FcγRIIB in immune thrombocytopenic purpura patients. J Clin Invest 118 (2008) 2939-2949
7. McMillan R., Wang L., Tomer A., et al. Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP. Blood 103 (2004) 1364-1369
8. Katsumata Y., Suzuki T., Kuwana M., et al. Autoantibody to c-Mpl (thrombopoietin receptor) in systemic lupus erythematosus: relationship to thrombocytopenia with megakaryocytic hypoplasia. Arthritis Rheum 46 (2002) 2148-2159
9. Rahman A., and Isenberg D.A. Systemic lupus erythematosus. N Engl J Med 358 (2008) 929-939
10. Ziakas P.D., Routsias J.G., Giannouli S., et al. Suspects in the tale of lupus-associated thrombocytopenia. Clin Exp Immunol 145 (2006) 71-80
11. Ziakas P.D., Poulou L.S., Giannouli S., et al. Thrombocytopenia in lupus: baseline C3 as an independent risk factor for relapse. Ann Rheum Dis 66 (2007) 130-131
12. Chen J.L., Huang X.M., Zeng X.J., et al. Hematological abnormalities in systemic lupus erythematosus and clinical significance there of: comparative analysis of 236 cases. Zhonghua Yi Xue Za Zhi 87 19 (2007) 1330-1333
13. Nojima J., Suehisa E., Kuratsune H., et al. High prevalence of thrombocytopenia in SLE patients with a high level of anticardiolipin antibodies combined with lupus anticoagulant. Am J Hematol 58 (1998) 55-60
14. Arnal C., Piette J.C., Léone J., et al. Treatment of severe immune thrombocytopenia associated with systemic lupus erythematosus: 59 cases. J Rheumatol 29 1 (2002) 75-83
15. Gernsheimer T. Chronic idiopathic thrombocytopenic purpura: mechanisms of pathogenesis. Oncologist 14 1 (2009) 12-21
16. George J.N., Raskob G.E., Shah S.R., et al. Drug-induced thrombocytopenia: a systematic review of published case reports. Ann Intern Med 129 (1998) 886-890
17. Cines D.B., Liebman H., and Stasi R. Pathobiology of secondary immune thrombocytopenia. Semin Hematol 46 Suppl 2 (2009) S2-14
18. Zandman-Goddard G., and Shoenfeld Y. HIV and autoimmunity. Autoimmun Rev 1 (2002) 329-337
19. Tincani A., Bazzani C., Zingarelli S., et al. Lupus and the antiphospholipid syndrome in pregnancy and obstetrics: clinical characteristics, diagnosis, pathogenesis, and treatment. Semin Thromb Hemost 34 3 (2008) 267-273
20. Manzi S., and Kao A.H. Systemic lupus erythematosus C. Treatment and assessment. In: Stone J.H., Klippel J.H., Crofford L.J., et al. (Eds). The primer on rheumatic diseases. 13th edition (2008), Springer, New York 327-338
21. Ramos-Casals M., Soto M., Cuadrado M., et al. Rituximab in systemic lupus erythematosus. A systematic review of off-label use in 188 cases. Lupus 18 (2009) 767-776
22. Wada M., Kamimoto H., Park S.Y., et al. Autoimmune hepatitis concomitant with hypergammaglobulinemic purpura, immune thrombocytopenia, and Sjögren's syndrome. Intern Med 40 4 (2001) 308-311
23. Daniels T. Sjögren's syndrome. In: Stone J.H., Klippel J.H., Crofford L.J., and White P.H. (Eds). The primer on rheumatic diseases. 13th edition (2008), Springer, New York 389-397
24. Delaleu N., Immervoll H., Cornelius J., et al. Biomarker profiles in serum and saliva of experimental Sjögren's syndrome: associations with specific autoimmune manifestations. Arthritis Res Ther 10 1 (2008) R22
25. Ramos-Casals M., Loustaud-Ratti V., De Vita S., et al. Sjögren syndrome associated with hepatitis C virus: a multicenter analysis of 137 cases. Medicine (Baltimore) 84 2 (2005) 81-89
26. Watanabe M., Fujimoto T., Iwano M., et al. Report of a patient of primary Sjögren syndrome, IgA nephropathy and chronic idiopathic thrombocytopenic purpura. Nihon Rinsho Meneki Gakkai Kaishi 25 (2002) 191-198
27. Yamada Y., and Kuroe K. A case of rheumatoid arthritis complicated with idiopathic thrombocytopenic purpura and Hashimoto's disease. Ryumachi 31 (1991) 413-419
28. Pathare S.K., Heycock C., and Hamilton J. TNF alpha blocker-induced thrombocytopenia. Rheumatology (Oxford) 45 (2006) 1313-1314
29. Vidal F., Fontova R., and Richart C. Severe neutropenia and thrombocytopenia associated with infliximab. Ann Intern Med 139 (2003) W-W63
30. Cantarini L., Tinazzi I., Biasi D., et al. Sulfasalazine-induced immune thrombocytopenia. Postgrad Med J 83 980 (2007) e1
31. Levin M.D., van t Veer M.B., de Veld J.C., et al. Two patients with acute thrombocytopenia following gold administration and five-year follow-up. Neth J Med 61 (2003) 223-225
32. Hara T., Mizuno Y., Akeda H., et al. Thrombocytopenia: a complication of Kawasaki disease. Eur J Pediatr 147 (1988) 51-53
33. Asano T., Sudoh M., Watanabe M., et al. Transient thrombocytopenia with large platelets in Kawasaki disease. Pediatr Hematol Oncol 24 (2007) 551-554
34. Matsuzaki K., Shiiya N., Kubota S., et al. A case of an ascending aortic aneurysm due to mesoaortitis complicated with idiopathic thrombocytopenic purpura. Ann Thorac Cardiovasc Surg 7 (2001) 315-318
35. Meyer M.F., Schnabel A., Schatz H., et al. Lack of association between antiphospholipid antibodies and thrombocytopenia in patients with Wegener's granulomatosis. Semin Arthritis Rheum 31 (2001) 4-11
36. Wiik A. Autoantibodies in vasculitis. Arthritis Res Ther 5 3 (2003) 147-152
37. Lin S.J., and Jaing T.H. Thrombocytopenia in systemic-onset juvenile chronic arthritis: report of two cases with unusual bone marrow features. Clin Rheumatol 18 3 (1999) 241-243
38. Fautrel B. Adult-onset Still disease. Best Pract Res Clin Rheumatol 22 5 (2008) 773-792
39. Gopal M., Cohn C.D., McEntire M.R., et al. Thrombotic thrombocytopenic purpura and adult onset Still's disease. Am J Med Sci 337 (2009) 373-376
40. Sayarlioglu M., Sayarlioglu H., Ozkaya M., et al. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome and adult onset Still's disease: case report and review of the literature. Mod Rheumatol 18 (2008) 403-406
41. Yoshizaki A., Kawakami A., Aramaki T., et al. Preferential recovery by an intensive initial therapy from hemophagocytic syndrome complicated with adult onset Still's disease presenting as agranulocytosis and hypercytokinemia. Clin Exp Rheumatol 26 (2008) 383
42. Passweg J., and Tyndall A. Autologous stem cell transplantation in autoimmune diseases. Semin Hematol 44 4 (2007) 278-285
43. Pope J.E. Other manifestations of mixed connective tissue disease. Rheum Dis Clin North Am 31 3 (2005) 519-533 vii
44. Richart C., and Pujol-Borrell R. Autoimmune hemolytic anemia and idiopathic thrombocytopenic purpura preceding a mixed connective tissue disease. Med Clin (Barc) 81 8 (1983) 370
45. Christopher-Stine L., and Plotz P.H. Myositis: an update on pathogenesis. Curr Opin Rheumatol 16 (2004) 700-706
46. Chang D.K., Yoo D.H., Kim T.H., et al. Induction of remission with intravenous immunoglobulin and cyclophosphamide in steroid-resistant Evans' syndrome associated with dermatomyositis. Clin Rheumatol 20 (2001) 63-66
47. Takaku T., Kuriyama Y., Shoji N., et al. Simultaneous development of factor V inhibitor and autoimmune thrombocytopenia in a patient with dermatomyositis. Rinsho Ketsueki 43 (2002) 1050-1054
48. Kaneoka H., Sasatomi Y., Miyagi K., et al. A rare case of dermatomyositis associated with immune-complex type glomerulonephritis, idiopathic thrombopenic purpura, pulmonary fibrosis and lung cancer. Clin Exp Rheumatol 21 (2003) 801-802
49. Williams S.F., Mincey B.A., and Calamia K.T. Inclusion body myositis associated with celiac sprue and idiopathic thrombocytopenic purpura. South Med J 96 (2003) 721-723
50. Tsai C.Y., Yu C.L., Tsai Y.Y., et al. Osteochondroma in a patient with juvenile ankylosing spondylitis associated with idiopathic thrombocytopenic purpura and alpha thalassemia. Scand J Rheumatol 25 (1996) 61-62
51. Uozumi K., Makino T., Shimotakahara S., et al. Cyclic thrombocytopenia with chronic thyroiditis and ankylosing spondylitis. Rinsho Ketsueki 33 (1992) 1215-1220
52. Brunasso A.M., and Massone C. Thrombocytopenia associated with the use of anti-tumor necrosis factor-alpha agents for psoriasis. J Am Acad Dermatol 60 (2009) 781-785
53. Miyakis S., Lockshin M.D., Atsumi T., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome. J Thromb Haemost 4 (2006) 295-306
54. Krause I., Blank M., Fraser A., et al. The association of thrombocytopenia with systemic manifestations in the antiphospholipid syndrome. Immunobiology 210 (2005) 749-754
55. Chong B.H., Brighton T.C., and Chesterman C.N. Antiphospholipid antibodies and platelets. Semin Thromb Hemost 21 (1995) 76-84
56. Galli M., Finazzi G., and Barbui T. Thrombocytopenia in the antiphospholipid syndrome. Br J Haematol 93 (1996) 1-5
57. Uthman I., Godeau B., Tahaer A., et al. The hematologic manifestations of the antiphospholipid syndrome. Blood Rev 22 (2008) 187-194
58. Bidot C.J., Jy W., Horstman L.L., et al. Antiphospholipid antibodies (APLA) in immune thrombocytopenic purpura (ITP) and antiphospholipid syndrome (APS). Am J Hematol 81 (2006) 391-396
59. Godeau B., Piette J.C., Fromont P., et al. Specific antiplatelet glycoprotein autoantibodies are associated with the thrombocytopenia of primary antiphospholipid syndrome. Br J Haematol 98 4 (1997) 873-879
60. Galli M., Luciani D., Bertoli G., et al. Anti beta-2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome. Blood 102 (2003) 2717-2723
61. Giannakopoulos B., Passam F., Rahgozar S., et al. Current concepts on the pathogenesis of the antiphospholipid syndrome. Blood 109 2 (2007) 422-430
62. Vega-Ostertag M.E., and Pierangeli S.S. Mechanisms of aPL-thrombosis: effect of aPL on endothelium and platelets. Curr Rheumatol Rep 9 (2007) 190-197
63. Nojima J., Suehisa E., Akita N., et al. Risk of arterial thrombosis in patients with anticardiolipin antibodies and lupus anticoagulant. Br J Haematol 96 (1997) 447-450
64. Macchi L., Rispal P., Clofent-Sanchez G., et al. Anti-platelet antibodies in patients with SLE and the primary anitphospholipid antibody syndrome: their relationship with the observed thrombocytopenia. Br J Haematol 98 (1997) 336-341
65. Meroni P.L., Rashchi E., Camera M., et al. Endothelial activation by aPL: a potential pathogenetic mechanism for the clinical manifestations of the syndrome. J Autoimmun 15 (2000) 237-240
66. Dunoyer-Geindre S., Boehlen F., Favier R., et al. Endothelial cell activation by immunoglobulins from patients with immune thrombocytopenic purpura or with antiphospholipid syndrome. Haematologica 93 4 (2008) 635-636
67. Atsumi T., Furukawa S., Amengual O., et al. Antiphospholipid antibody associated with thrombocytopenia and the paradoxical risk of thrombosis. Lupus 14 (2005) 499-504
68. Pierangeli S.S., Vega-Ostertag M.E., Raschi E., et al. Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies. Ann Rheum Dis 66 (2007) 1327-1333
69. Harris E.N., Gharavi A.E., Hegde U., et al. Anticardiolipin antibodies in autoimmune thrombocytopenic purpura. Br J Haematol 59 (1985) 231-234
70. Stasi R. Prevalence and clinical significance of elevated antiphospholipid antibodies in patients with idiopathic thrombocytopenic pupura. Blood 84 (1990) 4203-4208
71. Despujol C.P.D., Michel M., Khellaf, et al. Antiphospholipid antibodies in adults with immune thrombocytopenic purpura. Br J Haematol 142 (2008) 638-643
72. Diz-Kucukkaya R., Hachihanefioglu A., and Yenerel M. Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with the immune thrombocytopenic purpura: a prospective cohort study. Blood 98 (2001) 1760-1764
73. Kravitz M.S., and Shoenfeld Y. Thrombocytopenic conditions- autoimmunity and hypercoagulability: commonalities and differences in ITP, TTP, HIT, and APS. Am J Hematol 80 3 (2005) 232-242
74. Trapp R., Loew A., and Thuss-Patience P. Successful treatment of thrombocytopenia in primary antiphospholipid antibody syndrome with the anti-CD20 antibody rituximab-monitoring of antiphospholipid and anti GP antibodies: a case report. Ann Hematol 85 (2006) 134-135
75. Ruckert A., Glimm H., Lubbert M., et al. Successful treatment of life threatening Evans' syndrome due to antiphospholipid antibody syndrome by rituximab-based regimen: a case with long-term follow up. Lupus 17 (2008) 757